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CARDIOVASCULAR MEDICINE
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Background: In ischaemic cardiomyopathy, raised plasma concentrations of natriuretic peptides are
associated with a poor long term prognosis, while the presence of contractile reserve is a favourable sign.
Objective: To assess the relation between plasma natriuretic peptides and contractile reserve.
Design: Prospective observational study.
Setting: Tertiary referral centre.
Patients: 66 consecutive patients undergoing low dose dobutamine stress echocardiography to evaluate
contractile reserve in regions with contractile dysfunction at rest, divided into two groups: group 1, 31
patients with ischaemic cardiomyopathy (left ventricular ejection fraction ( 40%) and heart failure
symptoms; group 2, 35 patients with normal left ventricular function.
Main outcome measures: Plasma atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP),
measured using immunoradiometric assays. Contractile reserve was defined as an improvement in
segmental wall motion score during infusion of low dose dobutamine.
Results: Plasma ANP and BNP concentrations were higher in group 1 than in group 2 (mean (SD): ANP,
17.8 (32.8) v 7.2 (9.7), p , 0.005; BNP, 24.4 (69.0) v 5.0 (14.3) pmol/l, respectively; p , 0.001). In
group 1, the presence of contractile reserve was inversely related to ANP and BNP levels; however,
patients with contractile reserve had lower ANP and BNP concentrations than patients without contractile
reserve (ANP, 14.2 (9.1) v 24.2 (44.2), p , 0.05; BNP, 20.2 (25.5) v 37.5 (93.8) pmol/l, respectively;
p , 0.05).
Conclusions: Plasma natriuretic peptide concentrations are raised in patients with left ventricular
dysfunction, but in the presence of preserved myocardial contractile reserve, relatively low levels of ANP
and BNP are present.
I
schaemic left ventricular dysfunction is the principal cause
of congestive heart failure, which has a poor long term
prognosis.1–3 It has recently been proposed that atrial
natriuretic peptide (ANP) and brain natriuretic peptide
(BNP) may be useful in evaluating outcome in patients with
heart failure.4–8 ANP is a cardiac hormone which is
synthesised and secreted primarily in the atria, whereas
BNP is produced in the ventricles in response to changes in
wall stretch. Plasma concentrations of these natriuretic
peptides are raised in patients with left ventricular dysfunc-
tion, which is associated with a poor long term prognosis.4–8
In patients with depressed left ventricular function, the
presence of improved function during dobutamine infusion
(contractile reserve) is thought to be associated with a better
prognosis than in patients without contractile reserve. It
would be of interest to evaluate whether there are differences
in plasma levels of natriuretic peptides in patients with heart
failure with or without contractile reserve during low dose
dobutamine infusion.
We therefore studied a cohort of patients referred for low
dose dobutamine echocardiography and correlated the
findings with their plasma concentrations of natriuretic
peptides.
METHODS
Patient population and study protocol
The study population consisted of 66 consecutive patients
who were referred for low dose dobutamine stress echocar-
diography for the evaluation of contractile reserve in areas of
regional contractile dysfunction. The study population was
divided into two groups on the basis of their left ventricular
function and heart failure symptoms. Group 1 consisted of 31
patients with ischaemic cardiomyopathy (left ventricular
ejection fraction (40% because of chronic coronary artery
disease) and heart failure symptoms. Group 2 consisted of 35
patients with normal left ventricular function and no heart
failure symptoms. Because the aim of the study was to
evaluate the relation between plasma natriuretic peptides
and contractile reserve in patients with ischaemic cardiomyo-
pathy, those with primary cardiomyopathy, concomitant
significant valvar disease, or left ventricular hypertrophy
were excluded.
The study protocol was as follows:
N measurements of plasma levels of ANP and BNP using
immunoradiometric assays;
N assessment of global and regional left ventricular function
using resting cross sectional echocardiography;
N assessment of contractile reserve using low dose dobuta-
mine stress echocardiography.
The local medical ethics committee approved the study
protocol and all patients gave their informed consent.
Cardiac peptide measurements
Before stress echocardiography, blood samples were drawn
from a peripheral vein, after the patient had rested for at least
30 minutes in a supine position. The blood samples were
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collected in prechilled tubes containing edetic acid (EDTA,
1.9 mg/ml) and the protease inhibitor aprotonin (Trasylol,
100 kIU/ml) to prevent breakdown of the cardiac peptides.
Samples were stored on ice and promptly centrifuged at
3000 rpm (4 C˚) for 10 minutes. The plasma was separated
and stored at 280 C˚. Plasma concentrations of ANP and BNP
were determined using standard commercially available
immunoradiometric assay kits (Shionoria ANP and BNP kits,
Shionogi, Osaka, Japan).
Echocardiography
We employed a commercially available imaging system
(Hewlett Packard Sonos 5500, Andover, Massachusetts,
USA) and a 1.8 MHz transducer using second harmonic
imaging to optimise endocardial border visualisation. Cross
sectional imaging was done with the patient in the left lateral
position, and standard views (in cine-loop format) were
recorded on optical disk. Resting images were obtained first,
followed by low dose dobutamine stress echocardiography.
Dobutamine was given intravenously at a dose of 5 mg/kg
body weight per minute for five minutes, followed by a
10 mg/kg/min dose for five minutes.
Assessment of the left ventricular ejection fraction
The left ventricular ejection fraction (LVEF) was determined
off-line by the cross sectional biplane disk method using the
modified Simpson’s rule.9 The endocardial borders of the two
and four chamber apical views were digitally traced at end
diastole and end systole. Subsequently, left ventricular end
diastolic and end systolic volumes were derived and the LVEF
was calculated. An LVEF of (40% was considered indicative
of severe left ventricular dysfunction.
Assessment of contracti le reserve
Two experienced observers, unaware of the clinical data,
scored the digitised echocardiograms off-line. In case of
disagreement, a majority decision was achieved by a third
observer.
The left ventricle was divided into 16 segments according
to the American Society of Echocardiography.10 Regional wall
motion and systolic wall thickening were scored using a five
point grading scale: 1, normal; 2, mildly hypokinetic; 3,
severely hypokinetic; 4, akinetic; 5, dyskinetic. Segments
with severe hypokinesia, akinesia, or dyskinesia were
considered abnormal. The presence of contractile reserve
was defined as an improvement in segmental wall motion
score by>1 grade following infusion of low dose dobutamine
(5 mg/kg/min or 10 mg/kg/min) in two or more severely
dyssynergic segments.
Statistical analysis
Continuous data are expressed as mean (SD). Natriuretic
peptide concentrations are presented as medians (SD).
Percentages are rounded. Continuous variables are compared
using the Student t test for unpaired samples. Comparisons
between the natriuretic peptide concentrations were done
on log transformed concentrations. A probability value of
p , 0.05 was considered significant.
RESULTS
Patient characteristics
The clinical characteristics of the total study population of 66
patients are presented in table 1. In all, 31 patients had
ischaemic cardiomyopathy, with an LVEF of (40% and heart
failure symptoms. These comprised group 1. Their New York
Heart Association (NYHA) functional class was on average
2.7 (0.6). Group 2 comprised 35 patients with normal left
ventricular function and no heart failure symptoms.
Echocardiography
The LVEF at rest in group 1 was 33 (7)% compared with 60
(9)% in group 2 (p , 0.0001). Patients in group 1 had on
average 8.1 (6.5) dysfunctional segments, v 1.3 (3.7) in group
2 (p , 0.0001). The wall motion score index was 2.2 (0.9) in
group 1 and 1.2 (0.5) in group 2 (p , 0.0001). Low dose
dobutamine stress echocardiography was undertaken in all
patients without side effects. The haemodynamic changes in
response to dobutamine are presented in table 2. Contractile
reserve was observed in 19 patients in group 1 (61%) and in
all the patients in group 2.
Natriuretic peptide concentrations
The plasma concentrations of each natriuretic peptide were
significantly raised in patients with abnormal left ventricular
function. Figure 1 shows that the plasma ANP concentrations
were higher in group 1 than in group 2, at 17.8 (32.8) v 7.2
(9.7) pmol/l (p , 0.005). In line with this, plasma BNP
concentrations were also higher in group 1, at 24.4 (69.0) v
5.0 (14.3) pmol/l (p , 0.001). There was, however,
substantial variation in individual ANP and BNP values in
the patients in group 1 (fig 2).
Natriuretic peptides and contractile reserve in
patients with an LVEF of (40%
In group 1, the presence of contractile reserve was associated
with lower plasma concentrations of natriuretic peptides:
ANP, 14.2 (9.1) v 24.2 (44.2) pmol/l, p , 0.05 (fig 3); BNP,
20.2 (25.5) v 37.5 (93.8) pmol/l, p , 0.05.
DISCUSSION
Previous studies have shown that plasma natriuretic peptide
concentrations are raised in patients with congestive heart
failure; moreover, raised levels of these peptides are
Table 1 Baseline characteristics
Men/women 41 (62)/25 (38)
Age (years) (mean (SD)) 63 (13)
Diabetes mellitus 2 (3)
Hypercholesterolaemia 20 (30)
Smoking 8 (12)
History
Myocardial infarction 19 (29)
Coronary angioplasty 3 (5)
Coronary bypass surgery 10 (15)
Medical treatment
b Blockers 20 (30)
Calcium channel blockers 10 (15)
Nitrates 8 (12)
ACE inhibitors 13 (20)
Diuretics 8 (12)
Digoxin 5 (8)
Aspirin 26 (39)
Cholesterol lowering drugs 20 (30)
Data are n (%) unless stated otherwise.
ACE, angiotensin converting enzyme.
Table 2 Haemodynamic data during dobutamine
infusion
Dobutamine infusion
Baseline 5 mg/kg/min 10 mg/kg/min
Heart rate (beats/min) 74 (15) 81 (22)* 90 (26)*
Systolic BP (mmHg) 131 (22) 132 (25) 131 (23)
Diastolic BP (mmHg) 76 (12) 75 (13) 72 (11)*
Rate–pressure product 9595 (2446) 10 554 (3039) 11 693 (3862)
Values are mean (SD).
*p , 0.05 v baseline ; p , 0.05 v 5 mg/kg/min dobutamine infusion.
BP, blood pressure.
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associated with a poor prognosis.4–8 In the current study, we
found that patients with severe left ventricular dysfunction
had markedly raised plasma concentrations of natriuretic
peptides, although individual data varied substantially. In
group 1 (LVEF ( 40%), comparison of patients with and
without contractile reserve showed that those with no reserve
had significantly higher plasma levels of natriuretic peptides
and may be at higher risk of future cardiac events. The
natriuretic peptides play a role protecting the heart from
volume overload.11 The cardiac hormones ANP and BNP are
produced in the atria and ventricles, respectively, in response
to an increase in wall stretch or pressure. Raised plasma ANP
and BNP concentrations have a natriuretic and diuretic
effect. In addition, a high plasma BNP causes a fluid shift
from the capillary bed to the interstitium, thereby decreasing
preload and blood pressure. Hence, ANP and BNP are
functional counterparts of the renin-angiotensin-aldosterone
system. Accordingly, the plasma levels of these peptides have
been used to diagnose patients with heart failure.12 In the
present study, the plasma ANP and BNP concentrations were
significantly raised in the subset of patients with a severely
depressed LVEF.
In patients with ischaemic cardiomyopathy, the presence
of contractile reserve is related to the extent of viable tissue.13
Histopathological analysis of biopsies taken (during surgical
revascularisation) from segments with and without contrac-
tile reserve showed that a higher percentage of fibrosis was
present in the segments without contractile reserve.14 15 In
studies assessing prognosis, the presence of contractile
reserve has been shown to have a positive influence on long
term outcome.16 17
It is of interest that in the current study, patients with
contractile reserve had significantly lower plasma concentra-
tions of natriuretic peptides than patients without contractile
reserve. Accordingly, both prognostic indices appear to point
in the same direction. From the current study, the precise
interrelations between these two variables cannot be derived,
and further studies are needed to provide insight in the
pathophysiology underlying our observations. However, the
combined assessment of (high plasma levels of) natriuretic
peptides and (absence of) contractile reserve may help to
identify patients at relatively high risk for future events.
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Dynamic respiratory changes in hypertrophic cardiomyopathy
A
50 year old woman presented with severe exertional
dyspnoea. On physical examination, she had a 3/6
systolic ejection murmur that virtually disappeared
with inspiration. Transthoracic echocardiography demon-
strated findings typical of hypertrophic cardiomyopathy with
a pronounced increase in ventricular septal thickness and an
outflow gradient of 100 mm Hg. The patient underwent
cardiac catheterisation (panel below: Ao, aortic pressure, LA,
left atrial pressure, LV, left ventricular pressure, PA,
pulmonary artery pressure). In the resting state, there was
a significant outflow tract gradient between the left
ventricular and aortic pressure. However, with each inspira-
tion, there was a large decrease in the left ventricular outflow
tract gradient. The ‘‘spike and dome’’ morphology of the
aortic pressure curve virtually disappeared during peak
inspiration, indicating a notable resolution of the outflow
obstruction.
The pronounced decrease in the intensity of the systolic
murmur with inspiration is unique to hypertrophic cardio-
myopathy, secondary to the dynamic nature of the obstruc-
tion. The left ventricular outflow tract obstruction in patients
with hypertrophic cardiomyopathy is highly dependent upon
preload, afterload, and contractility. With inspiration, the
intrathoracic and intrapericardial pressures decrease to a
greater extent than the intracardiac pressures. As a result, the
left ventricular transmural pressure increases, increasing the
afterload on the left ventricle, thus decreasing the obstruction
and the left ventricular outflow tract gradient.
The dynamic changes of the murmur intensity with
respiration may help in the differential diagnosis of a systolic
murmur. In patients with hypertrophic cardiomyopathy,
there may be a notable decrease in the intensity of the
murmur during peak inspiration. Since the outflow tract
obstruction is also decreased, there may even be an increase
in arterial pressure, which has been called ‘‘reverse pulsus
paradoxus’’. In contrast, patients with right sided murmurs
will have an increase in the intensity of the murmur with
inspiration. In patients with murmurs of fixed outflow tract
obstruction or mitral regurgitation, there may be a slight
decrease in the intensity of the murmur with inspiration
from a slight decrease in preload but the aortic pressure will
also decrease.
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